PharmaCielo Ltd (PCLOF)
0.1659
+0.05
(+48.39%)
USD |
OTCM |
Jun 18, 13:14
PharmaCielo EPS Diluted (Quarterly): -0.0149 for Sept. 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.0149 |
| June 30, 2023 | -0.0149 |
| March 31, 2023 | -0.0148 |
| December 31, 2022 | -0.0147 |
| September 30, 2022 | -0.023 |
| June 30, 2022 | -0.0157 |
| March 31, 2022 | -0.0158 |
| December 31, 2021 | -0.0159 |
| September 30, 2021 | -0.0476 |
| June 30, 2021 | -0.0407 |
| March 31, 2021 | -0.0394 |
| December 31, 2020 | -0.1304 |
| September 30, 2020 | -0.06 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0505 |
| March 31, 2020 | -0.0447 |
| December 31, 2019 | -0.0985 |
| September 30, 2019 | -0.0303 |
| June 30, 2019 | -0.0374 |
| March 31, 2019 | -0.0601 |
| November 30, 2018 | -0.0459 |
| August 31, 2018 | -0.0749 |
| May 31, 2018 | -0.093 |
| February 28, 2018 | -0.7586 |
| November 30, 2017 | -0.0256 |
| August 31, 2017 | -0.032 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.1304
Minimum
Dec 2020
-0.0147
Maximum
Dec 2022
-0.0394
Average
-0.0338
Median
EPS Diluted (Quarterly) Benchmarks
| Rimrock Gold Corp | -0.0005 |
| InMed Pharmaceuticals Inc | -0.18 |
| Venus Concept Inc | -1.68 |
| Juva Life Inc | -0.01 |
| Lucy Scientific Discovery Inc | -1.484 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.057M |
| Revenue (Quarterly) | 0.2621M |
| Total Expenses (Quarterly) | 1.999M |
| Enterprise Value | 30.71M |
| Gross Profit Margin (Quarterly) | -99.29% |
| Profit Margin (Quarterly) | -784.9% |
| Earnings Yield | -35.73% |
| Normalized Earnings Yield | -32.18 |